Deferasirox 72205-0390-01
- Manufacturer
- Novadoz Pharmaceuticals Llc
- Dosage Form
- Tablet, For Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- November 20, 2019
- Listing Expires
- December 31, 2027
- Application
- ANDA209878
Need to source Deferasirox? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Deferasirox | 250 mg/1 |
Drug Class
Iron Chelator [EPC]Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]
Selected Package
72205-0390-01Selected30 TABLET, FOR SUSPENSION in 1 BOTTLE (72205-390-01)
Other packages for this product(3)
90 TABLET, FOR SUSPENSION in 1 BOTTLE (72205-390-02)
1000 TABLET, FOR SUSPENSION in 1 BOTTLE (72205-390-03)
10 BLISTER PACK in 1 CARTON (72205-390-05) / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK